Telomere profiling: Toward glioblastoma personalized medicine

Molecular Neurobiology

Volumn 47, Issue 1, 2013, Pages 64-76

  Ferrandon, Sylvain ^a   Saultier, Paul ^a   Carras, Julien ^b   Battiston Montagne, Priscillia ^a   Alphonse, Gersende ^a,b   Beuve, Michael ^c   Malleval, Céline ^d   Honnorat, Jérôme ^a,d   Slatter, Tania ^e   Hung, Noelyn ^e   Royds, Janice ^e   Rodriguez Lafrasse, Claire ^a,b   Poncet, Delphine ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c Lyon Sud Hospital ^*  (France)

^d CNRS   (France)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Glioma; Hadron; Irradiation; Telomerase; Telosome

Indexed keywords

ANTINEOPLASTIC AGENT; POT1 PROTEIN; PROTEIN; TELOMERASE; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; EX VIVO STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; ION THERAPY; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PROTEIN EXPRESSION; RADIOSENSITIVITY; REVIEW; TELOMERE HOMEOSTASIS; TREATMENT RESPONSE; TUMOR BIOPSY;

EID: 84872456916     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8363-9     Document Type: Review

References (63)

1. Preusser M, de Ribaupierre S, Wohrer A, Erridge SC, Hegi M, Weller M, Stupp R (2011) Current concepts and management of glioblastoma. Ann Neurol 70(1):9-21. doi: 10.1002/ana.22425
2. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98-110. doi: 10.1016/j.ccr.2009.12.020
3. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997-1003. doi: 10.1056/NEJMoa043331
4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996. doi: 10.1056/NEJMoa043330
5. Amelio D, Lorentini S, Schwarz M, Amichetti M (2010) Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues. Radiother Oncol 97(3):361-369. doi: 10.1016/j.radonc.2010.08.018
6. Li L, Quang TS, Gracely EJ, Kim JH, Emrich JG, Yaeger TE, Jenrette JM, Cohen SC, Black P, Brady LW (2010) A phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg 113(2):192-198. doi: 10.3171/2010.2.JNS091211
7. Mizoe JE, Tsujii H, Hasegawa A, Yanagi T, Takagi R, Kamada T, Tsuji H, Takakura K (2007) Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 69(2):390-396
8. Allen C, Borak TB, Tsujii H, Nickoloff JA (2011) Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy. Mutat Res 711(1-2):150-157. doi: 10.1016/j.mrfmmm.2011.02.012
9. Maucort-Boulch D, Baron MH, Pommier P, Weber DC, Mizoe JE, Rochat J, Boissel JP, Balosso J, Tsujii H, Amsallem E (2010) Rationale for carbon ion therapy in high-grade glioma based on a review and a meta-analysis of neutron beam trials. Cancer Radiother 14(1):34-41. doi: 10.1016/j.canrad.2009.08.141
10. Boldrini L, Pistolesi S, Gisfredi S, Ursino S, Ali G, Pieracci N, Basolo F, Parenti G, Fontanini G (2006) Telomerase activity and hTERT mRNA expression in glial tumors. Int J Oncol 28(6):1555-1560
11. Akiyama M, Yamada O, Kanda N, Akita S, Kawano T, Ohno T, Mizoguchi H, Eto Y, Anderson KC, Yamada H (2002) Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Lett 178(2):187-197
12. Serakinci N, Christensen R, Graakjaer J, Cairney CJ, Keith WN, Alsner J, Saretzki G, Kolvraa S (2007) Ectopically hTERT expressing adult human mesenchymal stem cells are less radiosensitive than their telomerase negative counterpart. Exp Cell Res 313(5):1056-1067
13. Gomez-Millan J, Goldblatt EM, Gryaznov SM, Mendonca MS, Herbert BS (2007) Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells. Int J Radiat Oncol Biol Phys 67(3):897-905
14. Wesbuer S, Lanvers-Kaminsky C, Duran-Seuberth I, Bolling T, Schafer KL, Braun Y, Willich N, Greve B (2010) Association of telomerase activity with radio- and chemosensitivity of neuroblastomas. Radiat Oncol 5:66. doi: 10.1186/1748-717X-5-66
15. Papanikolaou V, Athanassiou E, Dubos S, Dimou I, Papathanasiou I, Kitsiou-Tzeli S, Kappas C, Tsezou A (2011) hTERT regulation by NF-kappaB and c-myc in irradiated HER2-positive breast cancer cells. Int J Radiat Biol 87(6):609-621. doi: 10.3109/09553002.2011.572112
16. Ram R, Uziel O, Eldan O, Fenig E, Beery E, Lichtenberg S, Nordenberg Y, Lahav M (2009) Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via ras/phosphatidylinositol 3-kinase/Akt pathway. Clin Cancer Res 15(3):914-923. doi: 10.1158/1078-0432.CCR- 08-0792
17. Kurvinen K, Rantanen V, Syrjanen S, Johansson B (2006) Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity. Int J Radiat Biol 82(12):859-867
18. Zhong YH, Liao ZK, Zhou FX, Xie CH, Xiao CY, Pan DF, Luo ZG, Liu SQ, Zhou YF (2008) Telomere length inversely correlates with radiosensitivity in human carcinoma cells with the same tissue background. Biochem Biophys Res Commun 367(1):84-89. doi: 10.1016/j.bbrc.2007.12.078
19. Komuro Y, Watanabe T, Tsurita G, Muto T, Nagawa H (2005) Expression pattern of telomerase reverse transcriptase in rectal carcinoma predicts tumor radiosensitivity, local recurrence and disease-free survival. Hepato-Gastroenterology 52(64):985-989
20. Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, Seguchi H, Kishimoto S (1998) Changes in telomerase activity of advanced cancers of oral cavity and oropharynx during radiation therapy: correlation with clinical outcome. Int J Mol Med 2(3):301-307
21. Tchirkov A, Rolhion C, Kemeny JL, Irthum B, Puget S, Khalil T, Chinot O, Kwiatkowski F, Perissel B, Vago P, Verrelle P (2003) Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas. Br J Cancer 88(4):516-520
22. Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR, Royds JA (2003) Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361(9360):836-838
23. Martinez P, Blasco MA (2011) Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11(3):161-176. doi: 10.1038/nrc3025
24. Du G, Drexler GA, Friedland W, Greubel C, Hable V, Krucken R, Kugler A, Tonelli L, Friedl AA, Dollinger G (2011) Spatial dynamics of DNA damage response protein foci along the ion trajectory of high-LET particles. Radiat Res 176(6):706-715. doi: 10.1667/RR2592.1
25. Iwadate Y, Mizoe J, Osaka Y, Yamaura A, Tsujii H (2001) High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53. Int J Radiat Oncol Biol Phys 50(3):803-808
26. Kamlah F, Hanze J, Arenz A, Seay U, Hasan D, Juricko J, Bischoff B, Gottschald OR, Fournier C, Taucher-Scholz G, Scholz M, Seeger W, Engenhart-Cabillic R, Rose F (2011) Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma cells. Int J Radiat Oncol Biol Phys 80(5):1541-1549. doi: 10.1016/j.ijrobp.2011. 03.033
27. Cui X, Oonishi K, Tsujii H, Yasuda T, Matsumoto Y, Furusawa Y, Akashi M, Kamada T, Okayasu R (2011) Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. Cancer Res 71(10):3676-3687. doi: 10.1158/0008-5472.CAN-10-2926
28. Rieken S, Habermehl D, Wuerth L, Brons S, Mohr A, Lindel K, Weber K, Haberer T, Debus J, Combs SE (2011) Carbon ion irradiation inhibits glioma cell migration through downregulation of integrin expression. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2011.06.2004
29. Alphonse G, Aloy MT, Broquet P, Gerard JP, Louisot P, Rousson R, Rodriguez-Lafrasse C (2002) Ceramide induces activation of the mitochondrial/caspases pathway in Jurkat and SCC61 cells sensitive to gamma-radiation but activation of this sequence is defective in radioresistant SQ20B cells. Int J Radiat Biol 78(9):821-835
30. Beuve M, Alphonse G, Maalouf M, Colliaux A, Battiston-Montagne P, Jalade P, Balanzat E, Demeyer A, Bajard M, Rodriguez-Lafrasse C (2008) Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions. Int J Radiat Oncol Biol Phys 71(2):635-642
31. Poncet D, Belleville A, t'kint de Roodenbeke C, Roborel de Climens A, Ben Simon E, Merle-Beral H, Callet-Bauchu E, Salles G, Sabatier L, Delic J, Gilson E (2008) Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood 111(4):2388-2391
32. Leteurtre F, Li X, Gluckman E, Carosella ED (1997) Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells. Leukemia 11(10):1681-1689
33. Neuhof D, Ruess A, Wenz F, Weber KJ (2001) Induction of telomerase activity by irradiation in human lymphoblasts. Radiat Res 155(5):693-697
34. Satra M, Tsougos I, Papanikolaou V, Theodorou K, Kappas C, Tsezou A (2006) Correlation between radiation-induced telomerase activity and human telomerase reverse transcriptase mRNA expression in HeLa cells. Int J Radiat Biol 82(6):401-409
35. Hyeon Joo O, Hande MP, Lansdorp PM, Natarajan AT (1998) Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation. Mutat Res 401(1-2):121-131
36. He X, Qiao Q, Ge N, Nan J, Shen S, Wang Z, Yang Y, Bao G (2010) Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population. BMC Cancer 10:312. doi: 10.1186/1471-2407-10-312
37. Neuhof D, Bischof M, Debus J, Weber KJ (2007) Telomerase activity in peripheral blood mononuclear cells after whole body irradiation. Oncol Rep 17(4):865-869
38. Yajima T, Yagihashi A, Kameshima H, Kobayashi D, Hirata K, Watanabe N (2001) Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells. Br J Cancer 85(5):752-757
39. Loayza D, De Lange T (2003) POT1 as a terminal transducer of TRF1 telomere length control. Nature 423(6943):1013-1018
40. Chen YJ, Hakin-Smith V, Teo M, Xinarianos GE, Jellinek DA, Carroll T, McDowell D, MacFarlane MR, Boet R, Baguley BC, Braithwaite AW, Reddel RR, Royds JA (2006) Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma. Cancer Res 66(13):6473-6476
41. McDonald KL, McDonnell J, Muntoni A, Henson JD, Hegi ME, von Deimling A, Wheeler HR, Cook RJ, Biggs MT, Little NS, Robinson BG, Reddel RR, Royds JA (2010) Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol 69(7):729-736. doi: 10.1097/NEN.0b013e3181e576cf
42. Sampl S, Pramhas S, Stern C, Preusser M, Marosi C, Holzmann K (2012) Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade. Transl Oncol 5(1):56-65
43. Nakagami Y, Ito M, Hara T, Inoue T (2002) Loss of TRF2 by radiation-induced apoptosis in HL60 cells. Radiat Med 20(3):121-129
44. Ning H, Li T, Zhao L, Li T, Li J, Liu J, Liu Z, Fan D (2006) TRF2 promotes multidrug resistance in gastric cancer cells. Cancer Biol Ther 5(8):950-956
45. Wu L, Multani AS, He H, Cosme-Blanco W, Deng Y, Deng JM, Bachilo O, Pathak S, Tahara H, Bailey SM, Deng Y, Behringer RR, Chang S (2006) Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126(1):49-62
46. Perera SA, Maser RS, Xia H, McNamara K, Protopopov A, Chen L, Hezel AF, Kim CF, Bronson RT, Castrillon DH, Chin L, Bardeesy N, Depinho RA, Wong KK (2008) Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer. Carcinogenesis 29(4):747-753. doi: 10.1093/carcin/bgn050
47. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406(6796):641-645
48. Begus-Nahrmann Y, Hartmann D, Kraus J, Eshraghi P, Scheffold A, Grieb M, Rasche V, Schirmacher P, Lee HW, Kestler HA, Lechel A, Rudolph KL (2012) Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis. J Clin Invest 122(6):2283-2288. doi: 10.1172/JCI61745
49. Salhab M, Jiang WG, Newbold RF, Mokbel K (2007) The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome. Breast Cancer Res Treat 109:35-46
50. Fujii K, Sasahira T, Moriwaka Y, Oue N, Yasui W, Kuniyasu H (2008) Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer. Int J Mol Med 21(5):599-604
51. Tang T, Zhou FX, Lei H, Yu HJ, Xie CH, Zhou YF, Liu SQ (2009) Increased expression of telomere-related proteins correlates with resistance to radiation in human laryngeal cancer cell lines. Oncol Rep 21(6):1505-1509
52. Drissi R, Wu J, Hu Y, Bockhold C, Dome JS (2011) Telomere shortening alters the kinetics of the DNA damage response after ionizing radiation in human cells. Cancer Prev Res (Phila) 4(12):1973-1981. doi: 10.1158/1940-6207.CAPR-11- 0069
53. Soler D, Pampalona J, Tusell L, Genesca A (2009) Radiation sensitivity increases with proliferation-associated telomere dysfunction in nontransformed human epithelial cells. Aging Cell 8(4):414-425. doi: 10.1111/j.1474-9726.2009. 00488.x
54. Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM, Bouffler SD, Blasco MA (2000) Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 192(11):1625-1636
55. Latre L, Tusell L, Martin M, Miro R, Egozcue J, Blasco MA, Genesca A (2003) Shortened telomeres join to DNA breaks interfering with their correct repair. Exp Cell Res 287(2):282-288
56. Wong KK, Chang S, Weiler SR, Ganesan S, Chaudhuri J, Zhu C, Artandi SE, Rudolph KL, Gottlieb GJ, Chin L, Alt FW, DePinho RA (2000) Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet 26(1):85-88
57. Bhattacharyya S, Sandy A, Groden J (2010) Unwinding protein complexes in ALTernative telomere maintenance. J Cell Biochem 109(1):7-15. doi: 10.1002/jcb.22388
58. Opresko PL, Mason PA, Podell ER, Lei M, Hickson ID, Cech TR, Bohr VA (2005) POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates. J Biol Chem 280(37):32069-32080. doi: 10.1074/jbc.M505211200
59. Flynn RL, Centore RC, O'Sullivan RJ, Rai R, Tse A, Songyang Z, Chang S, Karlseder J, Zou L (2011) TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature 471(7339):532-536. doi: 10.1038/nature09772
60. Nakano T, Suzuki Y, Ohno T, Kato S, Suzuki M, Morita S, Sato S, Oka K, Tsujii H (2006) Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res 12(7 Pt 1):2185-2190. doi: 10.1158/1078-0432.CCR-05-1907
61. Oikawa S, Kawanishi S (1999) Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 453(3):365-368
62. Chuang TC, Moshir S, Garini Y, Chuang AY, Young IT, Vermolen B, van den Doel R, Mougey V, Perrin M, Braun M, Kerr PD, Fest T, Boukamp P, Mai S (2004) The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2:12. doi: 10.1186/1741-7007-2-121741-7007-2-12
63. R Development Core Team (2005) R: A language and environment for statistical computing, reference index version 2.2.1. R Foundation for Statistical Computing, Vienna, Austria. ISBN: 3-900051-07-0. Available at http://www.R-project.org